Mammalian DNA topoisomerase IIIα is essential in early embryogenesis

Targeted disruption of the mouse TOP3α gene encoding DNA topoisomerase IIIα was carried out to study the physiological functions of the mammalian type IA DNA topoisomerase. Whereas heterozygous top3α+/− mutant mice were found to resemble phenotypically their TOP3α+/+ litermates, no viable top3α−/− homozygotes were found among over 100 progeny of top3α+/− intercrosses. Examination of embryos dissected from decidual swellings and in vitro culturing of blastocysts from top3α+/− intercrosses showed that implantation of top3α−/− embryos and the induction of decidualization could occur, but viability of these embryos was severely compromised at an early stage of development. The requirement of mouse DNA topoisomerase IIIα during early embryogenesis is discussed in terms of its plausible role in chromosome replication and its interaction with the RecQ/SGS1 family of DNA helicases, whose members include the Bloom’s syndrome and the Werner’s syndrome gene products.

[1]  M. Meyn,et al.  Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the ataxia-telangiectasia phenotype. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Y. Tse‐Dinh,et al.  Regulation of Escherichia coli topA gene transcription: involvement of a sigmaS-dependent promoter. , 1997, Journal of molecular biology.

[3]  S Minoshima,et al.  One-megabase sequence analysis of the human immunoglobulin lambda gene locus. , 1997, Genome research.

[4]  R. Sternglanz,et al.  Human homologues of yeast helicase , 1996, Nature.

[5]  Y. Tse‐Dinh,et al.  Effect of the deletion of the σ32‐dependent promoter (P1) of the Escherichia coli topoisomerase I gene on thermotolerance , 1996, Molecular microbiology.

[6]  J. Wang,et al.  Human TOP3: a single-copy gene encoding DNA topoisomerase III. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Schellenberg,et al.  Positional Cloning of the Werner's Syndrome Gene , 1996, Science.

[8]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[9]  N. Ellis,et al.  The Bloom's syndrome gene product is homologous to RecQ helicases , 1995, Cell.

[10]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[11]  L. Liu,et al.  Overexpression of RNase H partially complements the growth defect of an Escherichia coli delta topA mutant: R-loop formation is a major problem in the absence of DNA topoisomerase I. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S Gangloff,et al.  The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase , 1994, Molecular and cellular biology.

[13]  L. Liu,et al.  Hypernegative supercoiling of the DNA template during transcription elongation in vitro. , 1994, The Journal of biological chemistry.

[14]  J. Wang,et al.  Identification of the yeast TOP3 gene product as a single strand-specific DNA topoisomerase. , 1992, The Journal of biological chemistry.

[15]  J. Miller,et al.  Cloning and sequencing of Escherichia coli mutR shows its identity to topB, encoding topoisomerase III , 1992, Journal of bacteriology.

[16]  T. Andoh,et al.  Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. , 1991, Cancer research.

[17]  J. Wang,et al.  DNA topoisomerases: why so many? , 1991, The Journal of biological chemistry.

[18]  P. Caron,et al.  The role of DNA topoisomerases in recombination and genome stability: A double-edged sword? , 1990, Cell.

[19]  J. Wallis,et al.  A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase , 1989, Cell.

[20]  R. Hertzberg,et al.  In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. , 1989, Cancer research.

[21]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[22]  D. W. Fry,et al.  Inhibition of type II topoisomerase by fostriecin. , 1988, Biochemical pharmacology.

[23]  R. Digate,et al.  Identification of a potent decatenating enzyme from Escherichia coli. , 1988, The Journal of biological chemistry.

[24]  J. Wang,et al.  Supercoiling of the DNA template during transcription. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Sternglanz,et al.  Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes , 1982, Cell.

[26]  K. Drlica,et al.  Escherichia coli DNA topoisomerase I mutants: Increased supercoiling is corrected by mutations near gyrase genes , 1982, Cell.